MBCP
Commercial- Indications
- Orthopedic surgery, Spine surgery, Dental surgery
Company intelligence / Profile preview
Biomatlante develops and commercializes innovative synthetic biomaterials for bone regeneration. Its products—including MBCP-based synthetic bone grafts and resorbable collagen membranes—are widely used in orthopedic, trauma, spine, dental/maxillofacial, stomatology, and ENT surgeries. The company’s solutions are supported by extensive clinical evidence for safety and efficacy. It collaborates with leading research institutions to drive innovation in biomaterials.
3 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biomatlante.